Latest News

Latest News

News from the World Hepatitis Alliance

Founder of the World Hepatitis Alliance appointed as Executive Director of the Medicines Patent Pool

19 Apr 2018 Bridie Taylor

Charles Gore continues his legacy of improving access to treatment for people living with hepatitis B and C Today the Medicines Patent Pool (MPP)...

APRIL 2018: HEP HEADLINES

13 Apr 2018 Bridie Taylor

Viral hepatitis is making the headlines. Here’s the latest news from the field of viral hepatitis this month. World Hepatitis Day 2018 campaign to...

World Hepatitis Alliance poised to “Find the Missing Millions” on World Hepatitis Day

28 Mar 2018 Bridie Taylor

Today, the World Hepatitis Alliance (WHA) launched this year’s World Hepatitis Day campaign entitled “Find the Missing Millions”. Under the theme of...

Hepatitis C among people who use drugs – Side Event at the Commission on Narcotic Drugs

12 Mar 2018 Bridie Taylor

The prevalence of hepatitis C among people who use drugs remains extremely high. However, the remarkable progress in science and medicine along with...

Close to 3 million access hepatitis C cure

9 Mar 2018 Bridie Taylor

On 8 March 2018, WHO launched the "Progress report on access to hepatitis C treatment" which is an update on the first edition, published in 2016. It...

MARCH 2018: HEP HEADLINES

2 Mar 2018 Bridie Taylor

Viral hepatitis is making the headlines. Here’s the latest news from the field of viral hepatitis this month. Malta steps up elimination efforts...

February 2018: Hep Headlines

6 Feb 2018 Bridie Taylor

Viral hepatitis is making the headlines. Here’s the latest news from the field of viral hepatitis this month. WHA welcomes a New President: Michael...

Deaths from liver cancer nearly double since the 1990s, new figures reveal

1 Feb 2018 Tara Farrell

[London, 1 February 2018] Over the last two decades, deaths caused by liver cancer have increased by 80% [1] , making it one of the fastest-growing...

Charles Gore steps down as WHA President

15 Dec 2017 Bridie Taylor

“After ten years as President of the World Hepatitis Alliance (WHA), my term has come to an end and I step down at the end of this year. As the World...

Worldwide 52 million children living with viral hepatitis

3 Nov 2017 Tara Farrell

World Hepatitis Alliance calls for better screening expectant mothers and treatment of children New data presented at this year’s World Hepatitis...

Miracle cure costs less than a budget airline flight

2 Nov 2017 Tara Farrell

New data shows hepatitis C cure can cost as low as 50 dollars, and data from over 1,000 patients shows it’s highly effective Embargo: 0001H Sao Paulo...

Nine countries now on track to eliminate hepatitis C

1 Nov 2017 Tara Farrell

On 1- 3 November, Ministers of Health, public health experts and NGOs will come together at the World Hepatitis Summit to advance the elimination of...

Viral Hepatitis kills more people than HIV, malaria or tuberculosis

15 Sep 2017 Tara Farrell

World Hepatitis Alliance calls for immediate political action to counteract fatal trend [London, 14 September] According to the Global Burden of...

Hepatitis A vaccination for Alaskan children has wiped out the virus

10 Aug 2017 Tara Farrell

A comprehensive hepatitis A vaccination program established in Alaska in the 1990s, which became a requirement for school entry in 2001, has...

Study shows universal vaccination has wiped out hepatitis B and associated liver cancer in Alaska’s young people

10 Aug 2017 Tara Farrell

Updated research presented at this year’s World Indigenous Peoples’ Conference on Viral Hepatitis in Anchorage, Alaska, USA (8-9 August) shows that...

New research shows indigenous peoples are much more likely to be infected by hepatitis B and/or C

9 Aug 2017 Bridie Taylor

A new meta-analysis of global hepatitis data -- presented at this year's World Indigenous Peoples' Conference on Viral Hepatitis in Anchorage, Alaska...

Cherokee Nation American Indian Tribe showing it is possible to eliminate hepatitis C

9 Aug 2017 Bridie Taylor

The Cherokee Nation American Indian population is aiming to eliminate hepatitis C virus (HCV) among its tribal citizens, where already almost half...

World Hepatitis Day sets the stage for the elimination of viral hepatitis - Press Release

28 Jul 2017 Tara Farrell

World Hepatitis Alliance calls for greater collaboration to reach 2030 World Health Organization targets...

An open letter to the Cochrane Collaboration

26 Jun 2017 Bridie Taylor

The members of the Executive Board of the World Hepatitis Alliance are elected to represent the more than 300 million people who have the experience...

“Findings from hepatitis C study should not deter patients from seeking treatment or governments from funding it” says World Hepatitis Alliance

13 Jun 2017 Tara Farrell

The World Hepatitis Alliance is concerned that the findings of the Cochrane Review on the new direct acting antiviral (DAA) hepatitis C drugs could...

Pages

News from infohep

Do fatigue and quality of life improve after hepatitis C is cured?

15 May 2018 Keith Alcorn
Patient-reported outcomes such as fatigue, vitality and mental health improve substantially in the two years following hepatitis C cure for people...

Does portal hypertension always improve after hepatitis C cure?

10 May 2018 Keith Alcorn
Although portal hypertension improves in the majority of people with hepatitis C and cirrhosis after hepatitis C is cured, not all people experience...

Combining hepatitis C therapy and buprenorphine leads to good outcomes for people who inject drugs

8 May 2018 Liz Highleyman
Offering hepatitis C treatment and opioid substitution therapy with buprenorphine at the same location can help increase adherence and reduce harms...

Switching to TAF improves safety in people with hepatitis B with kidney and bone risk factors

4 May 2018 Liz Highleyman
People with risk factors for tenofovir toxicity who switched from tenofovir disoproxil fumarate (TDF; Viread) to the new tenofovir alafenamide (TAF;...

Fewer non-liver cancers in people treated with DAAs compared to the interferon era

2 May 2018 Keith Alcorn
The risk of non-liver cancer is lower in people treated with direct-acting antivirals (DAAs) than in those treated with interferon and is probably an...

Myrcludex B plus tenofovir suppresses hepatitis delta

30 Apr 2018 Liz Highleyman
An experimental drug that blocks the entry of hepatitis B virus (HBV) and hepatitis delta virus (HDV) into liver cells suppressed HBV and HDV levels...

Sustained virological response reduces risk of serious cardiovascular disease in people with HCV-related compensated cirrhosis

27 Apr 2018 Michael Carter
Successful hepatitis C virus (HCV) therapy reduces the risk of a serious cardiovascular event in people with compensated liver cirrhosis, French...

Local therapy with sorafenib does not improve liver cancer survival

23 Apr 2018 Liz Highleyman
Combining sorafenib (Nexavar) with internal radiation therapy or transarterial chemoembolization did not improve overall survival for people with...

New EASL hepatitis C recommendations emphasise simplicity

23 Apr 2018 Liz Highleyman
The European Association for the Study of the Liver (EASL) released its latest hepatitis C treatment recommendations at the 2018 International Liver...

Routine clinical use of DAAs highly effective and safe in people with HIV/HCV in Europe

23 Apr 2018 Michael Carter
“Real life” data from across Europe shows that direct-acting antivirals (DAAs) cure hepatitis C in the vast majority of people with HIV and...